Healio

AGA urges antiviral prophylaxis for patients at high risk for hepatitis B reactivation

Please provide your email address to receive an email when new articles are posted on . AGA guidance strongly recommends antiviral prophylaxis for patients at high risk for hepatitis B reactivation.
Healio

Resuming antiviral therapy after withdrawal does not affect HBsAG seroclearance in HBV

Please provide your email address to receive an email when new articles are posted on . Adjusted analysis demonstrated no association between nucleos(t)ide analogue retreatment and HBsAg seroclearance ...
Monthly Prescribing Reference

ACIP Votes to End Routine Hep B Birth Dose Recommendation

The ACIP voted to recommend that the hepatitis B birth dose be optional for infants of HBsAg-negative mothers, a move strongly opposed by the American Academy of Pediatrics. The Centers for Disease ...
ascopubs.org

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication in cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) undergoing cytotoxic chemotherapy ...